Mechanisms of bone morphogenetic protein 2 (BMP2) stimulated inhibitor of DNA binding 3 (Id3) transcription

Molecular and Cellular Endocrinology

Volumn 332, Issue 1-2, 2011, Pages 242-252

  Ho, Catherine C ^a   Zhou, Xiang ^a   Mishina, Yuji ^b   Bernard, Daniel J ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

Author keywords

BMP; BMPR1A; BMPR2; FSH; Id; Pituitary; SMAD1 5

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; INHIBITOR OF DIFFERENTIATION 3; SMAD1 PROTEIN; SMAD5 PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CANCER CELL; CELL TYPE; COMPLEX FORMATION; CONTROLLED STUDY; ENHANCER REGION; FIBROBLAST; GENE ACTIVITY; GENE INDUCTION; GENE OVEREXPRESSION; GENETIC CONSERVATION; GONADOTROPIN SECRETING CELL; HUMAN; INTRACELLULAR SIGNALING; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY SEQUENCE; RNA INTERFERENCE; SPECIES DIFFERENCE; TRANSCRIPTION REGULATION;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; CELL LINE; CHO CELLS; CRICETINAE; CRICETULUS; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 2; INHIBITOR OF DIFFERENTIATION PROTEINS; MALE; MICE; MICE, TRANSGENIC; NEOPLASM PROTEINS; PROMOTER REGIONS, GENETIC; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; SMAD5 PROTEIN; TRANSCRIPTION, GENETIC;

EID: 78650524175     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.10.019     Document Type: Article

References (62)

1. Abe J. Bone morphogenetic protein (BMP) family, SMAD signaling and Id helix-loop-helix proteins in the vasculature: the continuous mystery of BMPs pleotropic effects. J. Mol. Cell Cardiol. 2006, 41:4-7.
2. Allendorph G.P., Vale W.W., Choe S. Structure of the ternary signaling complex of a TGF-β superfamily member. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:7643-7648.
3. Barone M.V., Pepperkok R., Peverali F.A., Philipson L. Id proteins control growth induction in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:4985-4988.
4. Belaguli N.S., Zhang M., Rigi M., Aftab M., Berger D.H. Cooperation between GATA4 and TGF-β signaling regulates intestinal epithelial gene expression. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292:G1520-G1533.
5. Bernard D.J. Both SMAD2 and SMAD3 mediate activin-stimulated expression of the follicle-stimulating hormone beta subunit in mouse gonadotrope cells. Mol. Endocrinol. 2004, 18:606-623.
6. Bernard D.J., Lee K.B., Santos M.M. Activin B can signal through both ALK4 and ALK7 in gonadotrope cells. Reprod. Biol. Endocrinol. 2006, 4:52.
7. Chen X., Zankl A., Niroomand F., Liu Z., Katus H.A., Jahn L., Tiefenbacher C. Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC. J. Mol. Cell Cardiol. 2006, 41:26-33.
8. Christy B.A., Sanders L.K., Lau L.F., Copeland N.G., Jenkins N.A., Nathans D. An Id-related helix-loop-helix protein encoded by a growth factor-inducible gene. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:1815-1819.
9. Coppe J.P., Smith A.P., Desprez P.Y. Id proteins in epithelial cells. Exp. Cell Res. 2003, 285:131-145.
10. Davis B.N., Hilyard A.C., Lagna G., Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008, 454:56-61.
11. The TGF-β Family 2008, 121-139. Cold Spring Harbor Laboratory Press, Cold Spring Harbor. R. Derynck, K. Miyazono (Eds.).
12. Ebisawa T., Tada K., Kitajima I., Tojo K., Sampath T.K., Kawabata M., Miyazono K., Imamura T. Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. J. Cell Sci. 1999, 112(Pt 20):3519-3527.
13. Faure M.O., Nicol L., Fabre S., Fontaine J., Mohoric N., McNeilly A., Taragnat C. BMP-4 inhibits follicle-stimulating hormone secretion in ewe pituitary. J. Endocrinol. 2005, 186:109-121.
14. Gilboa L., Nohe A., Geissendorfer T., Sebald W., Henis Y.I., Knaus P. Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors. Mol. Biol. Cell. 2000, 11:1023-1035.
15. Ho C.C., Bernard D.J. Bone morphogenetic protein 2 signals via BMPR1A to regulate murine follicle-stimulating hormone beta subunit transcription. Biol. Reprod. 2009, 81:133-141.
16. Ho C.C., Bernard D.J. Bone morphogenetic protein 2 acts via inhibitor of DNA binding proteins to synergistically regulate follicle-stimulating hormone β transcription with activin A. Endocrinology 2010, 151(7):3445-3453.
17. Hoodless P.A., Haerry T., Abdollah S., Stapleton M., O'Connor M.B., Attisano L., Wrana J.L. MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 1996, 85:489-500.
18. Hua H., Zhang Y.Q., Dabernat S., Kritzik M., Dietz D., Sterling L., Sarvetnick N. BMP4 regulates pancreatic progenitor cell expansion through Id2. J. Biol. Chem. 2006, 281:13574-13580.
19. Huang H.J., Wu J.C., Su P., Zhirnov O., Miller W.L. A novel role for bone morphogenetic proteins in the synthesis of follicle-stimulating hormone. Endocrinology 2001, 142:2275-2283.
20. Inman G.J., Nicolas F.J., Callahan J.F., Harling J.D., Gaster L.M., Reith A.D., Laping N.J., Hill C.S. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4 ALK5, and ALK7. Mol. Pharmacol. 2002, 62:65-74.
21. Ishida W., Hamamoto T., Kusanagi K., Yagi K., Kawabata M., Takehara K., Sampath T.K., Kato M., Miyazono K. Smad6 is a Smad1/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter. J. Biol. Chem. 2000, 275:6075-6079.
22. Kaneko K., Li X., Zhang X., Lamberti J.J., Jamieson S.W., Thistlethwaite P.A. Endothelial expression of bone morphogenetic protein receptor type 1a is required for atrioventricular valve formation. Ann. Thorac. Surg. 2008, 85:2090-2098.
23. Karaulanov E., Knochel W., Niehrs C. Transcriptional regulation of BMP4 synexpression in transgenic Xenopus. EMBO J. 2004, 23:844-856.
24. Karaya K., Mori S., Kimoto H., Shima Y., Tsuji Y., Kurooka H., Akira S., Yokota Y. Regulation of Id2 expression by CCAAT/enhancer binding protein beta. Nucleic Acids Res. 2005, 33:1924-1934.
25. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., Rosen V., Wozney J.M., Fujisawa-Sehara A., Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 1994, 127:1755-1766.
26. Katagiri T., Imada M., Yanai T., Suda T., Takahashi N., Kamijo R. Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis. Genes Cells 2002, 7:949-960.
27. Kim J., Johnson K., Chen H.J., Carroll S., Laughon A. Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. Nature 1997, 388:304-308.
28. Korchynskyi O., ten Dijke P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J. Biol. Chem. 2002, 277:4883-4891.
29. Kusanagi K., Inoue H., Ishidou Y., Mishima H.K., Kawabata M., Miyazono K. Characterization of a bone morphogenetic protein-responsive Smad-binding element. Mol. Biol. Cell. 2000, 11:555-565.
30. Lamba P., Santos M.M., Philips D.P., Bernard D.J. Acute regulation of murine follicle-stimulating hormone beta subunit transcription by activin A. J. Mol. Endocrinol. 2006, 36:201-220.
31. Lee K.B., Khivansara V., Santos M.M., Lamba P., Yuen T., Sealfon S.C., Bernard D.J. Bone morphogenetic protein 2 and activin A synergistically stimulate follicle-stimulating hormone beta subunit transcription. J. Mol. Endocrinol. 2007, 38:315-330.
32. Liu J., Wilson S., Reh T. BMP receptor 1b is required for axon guidance and cell survival in the developing retina. Dev. Biol. 2003, 256:34-48.
33. Lopez-Rovira T., Chalaux E., Massague J., Rosa J.L., Ventura F. Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene. J. Biol. Chem. 2002, 277:3176-3185.
34. Massague J., Seoane J., Wotton D. Smad transcription factors. Genes Dev. 2005, 19:2783-2810.
35. Mishina Y., Hanks M.C., Miura S., Tallquist M.D., Behringer R.R. Generation of Bmpr/Alk3 conditional knockout mice. Genesis 2002, 32:69-72.
36. Miura S., Singh A.P., Mishina Y. Bmpr1a is required for proper migration of the AVE through regulation of Dkk1 expression in the pre-streak mouse embryo. Dev. Biol. 2010, 341:246-254.
37. Miyazawa K., Shinozaki M., Hara T., Furuya T., Miyazono K. Two major Smad pathways in TGF-β superfamily signalling. Genes Cells 2002, 7:1191-1204.
38. Miyazono K. Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. Bone 1999, 25:91-93.
39. Miyazono K., Miyazawa K. Id: a target of BMP signaling. Sci. STKE 2002, 2002:pe40.
40. Miyazono K., Kamiya Y., Morikawa M. Bone morphogenetic protein receptors and signal transduction. J. Biochem. 2010, 147:35-51.
41. Nakahiro T., Kurooka H., Mori K., Sano K., Yokota Y. Identification of BMP responsive elements in the mouse Id2 gene. Biochem. Biophys. Res. Commun. 2010, 399(3):416-421.
42. Nicol L., Faure M.O., McNeilly J.R., Fontaine J., Taragnat C., McNeilly A.S. Bone morphogenetic protein-4 interacts with activin and GnRH to modulate gonadotrophin secretion in LβT2 gonadotrophs. J. Endocrinol. 2008, 196:497-507.
43. Nishitoh H., Ichijo H., Kimura M., Matsumoto T., Makishima F., Yamaguchi A., Yamashita H., Enomoto S., Miyazono K. Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5. J. Biol. Chem. 1996, 271:21345-21352.
44. Nohe A., Hassel S., Ehrlich M., Neubauer F., Sebald W., Henis Y.I., Knaus P. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J. Biol. Chem. 2002, 277:5330-5338.
45. Otsuka F., Shimasaki S. A novel function of bone morphogenetic protein-15 in the pituitary: selective synthesis and secretion of FSH by gonadotropes. Endocrinology 2002, 143:4938-4941.
46. Peng Y., Kang Q., Luo Q., Jiang W., Si W., Liu B.A., Luu H.H., Park J.K., Li X., Luo J., Montag A.G., Haydon R.C., He T.C. Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J. Biol. Chem. 2004, 279:32941-32949.
47. Samanta J., Kessler J.A. Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. Development 2004, 131:4131-4142.
48. Shepherd T.G., Theriault B.L., Nachtigal M.W. Autocrine BMP4 signalling regulates ID3 proto-oncogene expression in human ovarian cancer cells. Gene 2008, 414:95-105.
49. Shimasaki S., Moore R.K., Otsuka F., Erickson G.F. The bone morphogenetic protein system in mammalian reproduction. Endocr. Rev. 2004, 25:72-101.
50. Sieber C., Kopf J., Hiepen C., Knaus P. Recent advances in BMP receptor signaling. Cytokine Growth Factor Rev. 2009, 20:343-355.
51. ten Dijke P., Yamashita H., Sampath T.K., Reddi A.H., Estevez M., Riddle D.L., Ichijo H., Heldin C.H., Miyazono K. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem. 1994, 269:16985-16988.
52. Therrien M., Drouin J. Cell-specific helix-loop-helix factor required for pituitary expression of the pro-opiomelanocortin gene. Mol. Cell Biol. 1993, 13:2342-2353.
53. Tian F., Zhou A.X., Smits A.M., Larsson E., Goumans M.J., Heldin C.H., Boren J., Akyurek L.M. Endothelial cells are activated during hypoxia via endoglin/ALK-1/SMAD1/5 signaling in vivo and in vitro. Biochem. Biophys. Res. Commun. 2010, 392:283-288.
54. Urist M.R. Bone: formation by autoinduction. Science 1965, 150:893-899.
55. Valdimarsdottir G., Goumans M.J., Rosendahl A., Brugman M., Itoh S., Lebrin F., Sideras P., ten Dijke P. Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells. Circulation 2002, 106:2263-2270.
56. Vinals F., Reiriz J., Ambrosio S., Bartrons R., Rosa J.L., Ventura F. BMP-2 decreases Mash1 stability by increasing Id1 expression. EMBO J. 2004, 23:3527-3537.
57. Xu X., Yin Z., Hudson J.B., Ferguson E.L., Frasch M. Smad proteins act in combination with synergistic and antagonistic regulators to target Dpp responses to the Drosophila mesoderm. Genes Dev. 1998, 12:2354-2370.
58. Yang J., Davies R.J., Southwood M., Long L., Yang X., Sobolewski A., Upton P.D., Trembath R.C., Morrell N.W. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension. Circ. Res. 2008, 102:1212-1221.
59. Yang J., Li X., Al-Lamki R.S., Southwood M., Zhao J., Lever A.M., Grimminger F., Schermuly R.T., Morrell N.W. Smad-dependent and Smad-independent induction of Id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo. Circ. Res. 2010, 107:252-262.
60. Yeh K., Lim R.W. Genomic organization and promoter analysis of the murine Id3 gene. Gene 2000, 254:163-171.
61. Yu P.B., Beppu H., Kawai N., Li E., Bloch K.D. Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells. J. Biol. Chem. 2005, 280:24443-24450.
62. Yu P.B., Deng D.Y., Beppu H., Hong C.C., Lai C., Hoyng S.A., Kawai N., Bloch K.D. Bone morphogenetic protein (BMP) type II receptor is required for BMP-mediated growth arrest and differentiation in pulmonary artery smooth muscle cells. J. Biol. Chem. 2008, 283:3877-3888.